Close Menu

A European Union report says that EU countries have grown their research force and attracted record amounts of R&D funding. However, Science points out that the EU is behind in attaining its self-imposed goal of reaching 3 percent R&D intensity (research spending as a percent of GDP) by 2010, coming in at 1.84 percent, though that figure varies by country.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.